Millennium Pharmacon International (SDPC) — Capital Reinvestment Ratio
Millennium Pharmacon International (SDPC) has a Capital Reinvestment Ratio of 0.02x as of March 2025, meaning it reinvests 0% of its operating cash flow (Rp70.29 Billion) in capital expenditures (Rp1.09 Billion). Check Millennium Pharmacon International tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Millennium Pharmacon International Capital Reinvestment Ratio (2004–2022)
This chart tracks Millennium Pharmacon International's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see SDPC cash generation efficiency.
Annual Capital Reinvestment Ratio for Millennium Pharmacon International (2004–2022)
Year-by-year Capital Reinvestment Ratio for Millennium Pharmacon International from 2004 to 2022. See Millennium Pharmacon International (SDPC) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (IDR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.36x | Rp41.00 Billion | Rp14.68 Billion | ▲ +573.3% |
| 2020 | 0.05x | Rp71.69 Billion | Rp3.81 Billion | ▼ -96.0% |
| 2018 | 1.35x | Rp4.72 Billion | Rp6.35 Billion | ▼ -9.3% |
| 2017 | 1.48x | Rp4.46 Billion | Rp6.61 Billion | ▲ +160.6% |
| 2012 | 0.57x | Rp2.19 Billion | Rp1.25 Billion | ▼ -21.3% |
| 2007 | 0.72x | Rp4.57 Billion | Rp3.31 Billion | ▼ -26.7% |
| 2006 | 0.99x | Rp802.62 Million | Rp792.17 Million | ▲ +59.7% |
| 2004 | 0.62x | Rp2.72 Billion | Rp1.68 Billion | — |